Why Poulenc May Unload RorerBy
At the height of late-'80s takeover frenzy, Rorer Group was among the most sought-after pharmaceutical houses. It was no surprise when, in 1990, French chemical giant Rhone-Poulenc bagged it. Rorer, which makes drugs to fight cardiovascular, respiratory, and infectious diseases, as well as cancer and allergies, became Rhone-Poulenc Rorer (RPR).
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.